-
1
-
-
23644460299
-
Time-trends in the epidemiology of peptic ulcer bleeding
-
Ohmann C, Imhof M, Ruppert C, Janzik U, Vogt C, Frieling T et al. Time-trends in the epidemiology of peptic ulcer bleeding. Scand J Gastroenterol 2005;40:914-20.
-
(2005)
Scand J Gastroenterol
, vol.40
, pp. 914-920
-
-
Ohmann, C.1
Imhof, M.2
Ruppert, C.3
Janzik, U.4
Vogt, C.5
Frieling, T.6
-
3
-
-
0037068999
-
Bleeding risks of antithrombotic therapy
-
Fitzmaurice DA, Blann AD, Lip GY. Bleeding risks of antithrombotic therapy. BMJ 2002;325:828-31.
-
(2002)
BMJ
, vol.325
, pp. 828-831
-
-
Fitzmaurice, D.A.1
Blann, A.D.2
Lip, G.Y.3
-
4
-
-
10444278105
-
Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis
-
Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C et al. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. Chest 2004;126:1938-45.
-
(2004)
Chest
, vol.126
, pp. 1938-1945
-
-
Reynolds, M.W.1
Fahrbach, K.2
Hauch, O.3
Wygant, G.4
Estok, R.5
Cella, C.6
-
5
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
-
Antithrombotic Trialists' Collaboration.
-
Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
6
-
-
0018136725
-
Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition
-
Whitlon DS, Sadowski JA, Suttie JW. Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition. Biochemistry (Mosc) 1978;17:1371-7.
-
(1978)
Biochemistry (Mosc)
, vol.17
, pp. 1371-1377
-
-
Whitlon, D.S.1
Sadowski, J.A.2
Suttie, J.W.3
-
7
-
-
0015237292
-
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
-
Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232-5.
-
(1971)
Nat New Biol
, vol.231
, pp. 232-235
-
-
Vane, J.R.1
-
8
-
-
0142165030
-
The mechanism of action of aspirin
-
Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res 2003;110:255-8.
-
(2003)
Thromb Res
, vol.110
, pp. 255-258
-
-
Vane, J.R.1
Botting, R.M.2
-
9
-
-
0026559668
-
Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase
-
Mills DC, Puri R, Hu CJ, Minniti C, Grana G, Freedman MD et al. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb 1992;12:430-6.
-
(1992)
Arterioscler Thromb
, vol.12
, pp. 430-436
-
-
Mills, D.C.1
Puri, R.2
Hu, C.J.3
Minniti, C.4
Grana, G.5
Freedman, M.D.6
-
10
-
-
12344294328
-
Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design
-
Pettersen AA, Seljeflot I, Abdelnoor M, Arnesen H. Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design. Scand Cardiovasc J 2004;38:353-6.
-
(2004)
Scand Cardiovasc J
, vol.38
, pp. 353-356
-
-
Pettersen, A.A.1
Seljeflot, I.2
Abdelnoor, M.3
Arnesen, H.4
-
11
-
-
0034094923
-
Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies
-
Hagberg IA, Lyberg T. Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies. Platelets 2000;11:137-50.
-
(2000)
Platelets
, vol.11
, pp. 137-150
-
-
Hagberg, I.A.1
Lyberg, T.2
-
12
-
-
0242401773
-
Calibrated automated thrombin generation measurement in clotting plasma
-
Hemker HC, Giesen P, Al DR, Regnault V, De SE, Wagenvoord R et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003;33:4-15.
-
(2003)
Pathophysiol Haemost Thromb
, vol.33
, pp. 4-15
-
-
Hemker, H.C.1
Giesen, P.2
Al, D.R.3
Regnault, V.4
De, S.E.5
Wagenvoord, R.6
-
13
-
-
34249814885
-
Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression
-
Sandgren P, Hansson M, Gulliksson H, Shanwell A. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression. Vox Sang 2007;93:27-36.
-
(2007)
Vox Sang
, vol.93
, pp. 27-36
-
-
Sandgren, P.1
Hansson, M.2
Gulliksson, H.3
Shanwell, A.4
-
14
-
-
37149047880
-
Enhanced platelet aggregation and activation under conditions of hypothermia
-
Xavier RG, White AE, Fox SC, Wilcox RG, Heptinstall S. Enhanced platelet aggregation and activation under conditions of hypothermia. Thromb Haemost 2007;98:1266-75.
-
(2007)
Thromb Haemost
, vol.98
, pp. 1266-1275
-
-
Xavier, R.G.1
White, A.E.2
Fox, S.C.3
Wilcox, R.G.4
Heptinstall, S.5
-
15
-
-
67349263394
-
Trafficking and function of the tetraspanin CD63
-
Pols MS, Klumperman J. Trafficking and function of the tetraspanin CD63. Exp Cell Res 2009;315:1584-92.
-
(2009)
Exp Cell Res
, vol.315
, pp. 1584-1592
-
-
Pols, M.S.1
Klumperman, J.2
-
16
-
-
0024522749
-
Inhibition of human platelet function in vitro and ex vivo by acetaminophen
-
Lages B, Weiss HJ. Inhibition of human platelet function in vitro and ex vivo by acetaminophen. Thromb Res 1989;53:603-13.
-
(1989)
Thromb Res
, vol.53
, pp. 603-613
-
-
Lages, B.1
Weiss, H.J.2
-
17
-
-
0033981299
-
Platelet dysfunction after intravenous ketorolac or propacetamol
-
Niemi TT, Backman JT, Syrjala MT, Viinikka LU, Rosenberg PH. Platelet dysfunction after intravenous ketorolac or propacetamol. Acta Anaesthesiol Scand 2000;44:69-74.
-
(2000)
Acta Anaesthesiol Scand
, vol.44
, pp. 69-74
-
-
Niemi, T.T.1
Backman, J.T.2
Syrjala, M.T.3
Viinikka, L.U.4
Rosenberg, P.H.5
-
19
-
-
13244262832
-
Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection
-
Maurer-Spurej E. Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection. Cell Mol Life Sci 2005;62:159-70.
-
(2005)
Cell Mol Life Sci
, vol.62
, pp. 159-170
-
-
Maurer-Spurej, E.1
-
20
-
-
0033598594
-
Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study
-
de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 1999;319:1106-9.
-
(1999)
BMJ
, vol.319
, pp. 1106-1109
-
-
de Abajo, F.J.1
Rodriguez, L.A.2
Montero, D.3
-
21
-
-
33645046396
-
Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis
-
Wessinger S, Kaplan M, Choi L, Williams M, Lau C, Sharp L et al. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 2006;23:937-44.
-
(2006)
Aliment Pharmacol Ther
, vol.23
, pp. 937-944
-
-
Wessinger, S.1
Kaplan, M.2
Choi, L.3
Williams, M.4
Lau, C.5
Sharp, L.6
-
22
-
-
0002656782
-
Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs
-
Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998;158:33-9.
-
(1998)
Arch Intern Med
, vol.158
, pp. 33-39
-
-
Garcia Rodriguez, L.A.1
Cattaruzzi, C.2
Troncon, M.G.3
Agostinis, L.4
-
23
-
-
0036267997
-
Calcium channel blocker use and gastrointestinal tract bleeding among older adults
-
Kaplan RC, Heckbert SR, Koepsell TD, Rosendaal FR, Furberg CD, Cooper LS et al. Calcium channel blocker use and gastrointestinal tract bleeding among older adults. Age Ageing 2002;31:217-8.
-
(2002)
Age Ageing
, vol.31
, pp. 217-218
-
-
Kaplan, R.C.1
Heckbert, S.R.2
Koepsell, T.D.3
Rosendaal, F.R.4
Furberg, C.D.5
Cooper, L.S.6
-
24
-
-
0029873619
-
Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67years old
-
Pahor M, Guralnik JM, Furberg CD, Carbonin P, Havlik R. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67years old. Lancet 1996;347:1061-5.
-
(1996)
Lancet
, vol.347
, pp. 1061-1065
-
-
Pahor, M.1
Guralnik, J.M.2
Furberg, C.D.3
Carbonin, P.4
Havlik, R.5
-
25
-
-
0032884270
-
Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process
-
Chou TC, Li CY, Yen MH, Ding YA. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process. Biochem Pharmacol 1999;58:1657-63.
-
(1999)
Biochem Pharmacol
, vol.58
, pp. 1657-1663
-
-
Chou, T.C.1
Li, C.Y.2
Yen, M.H.3
Ding, Y.A.4
-
26
-
-
40949103552
-
Enhanced nitric oxide and cyclic GMP formation plays a role in the anti-platelet activity of simvastatin
-
Chou TC, Lin YF, Wu WC, Chu KM. Enhanced nitric oxide and cyclic GMP formation plays a role in the anti-platelet activity of simvastatin. Br J Pharmacol 2008;153:1281-7.
-
(2008)
Br J Pharmacol
, vol.153
, pp. 1281-1287
-
-
Chou, T.C.1
Lin, Y.F.2
Wu, W.C.3
Chu, K.M.4
-
27
-
-
30944454630
-
Inhibitory effect of aqueous extracts of some herbs on human platelet aggregation in vitro
-
Pierre S, Crosbie L, Duttaroy AK. Inhibitory effect of aqueous extracts of some herbs on human platelet aggregation in vitro. Platelets 2005;16:469-73.
-
(2005)
Platelets
, vol.16
, pp. 469-473
-
-
Pierre, S.1
Crosbie, L.2
Duttaroy, A.K.3
-
28
-
-
0037816232
-
Effect of low doses of ethanol on platelet function in long-life abstainers and moderate-wine drinkers
-
Miceli M, Alberti L, Bennardini F, Di SP, Seghieri G, Rao GH et al. Effect of low doses of ethanol on platelet function in long-life abstainers and moderate-wine drinkers. Life Sci 2003;73:1557-66.
-
(2003)
Life Sci
, vol.73
, pp. 1557-1566
-
-
Miceli, M.1
Alberti, L.2
Bennardini, F.3
Di, S.P.4
Seghieri, G.5
Rao, G.H.6
|